Abstract
A male in his 30s was diagnosed with acute central serous chorioretinopathy (CSC) in the left eye for 3 months and after an unsuccessful oral eplerenone therapy presented with persistent disease. Continuing vision blur, worsening subretinal fluid, and absent fluorescein leak on angiography prompted us (based on earlier experience) to use the novel therapy of dexamethasone intravitreal implant. Successful resolution was noted in 2 months with visual improvement. We describe the first use of an intravitreal long-acting corticosteroid implant in a case of persistent, simple CSC with a favorable outcome.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
